Enanta Pharma (ENTA) Tops Q2 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Enanta Pharma (ENTA) Tops Q2 EPS by 10c

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2017

May 8, 2017 4:01 PM EDT

Webcast and Conference Call today at 4:30 p.m. ET

Royalty revenue was $9.0 million R&D expense increased to $13.0 million in support of pipeline development Cash and marketable securities totaled $240.9 million at March 31, 2017

WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today reported financial results for its fiscal second quarter ended March 31, 2017.

... More